Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment.

@article{Svae2008PrionSO,
  title={Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment.},
  author={Tor-Einar Svae and Andrea Neisser-Svae and A. Bailey and Herwig Reichl and Lothar Biesert and Torben Schmidt and A. Sharif Heger and Juergen R Roemisch},
  journal={Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis},
  year={2008},
  volume={39 1},
  pages={59-67}
}
Reports about transfusion-related transmissions of variant Creutzfeldt-Jakob disease have urged the need for more information regarding the risk for prion contaminated units in the blood supply and the safety of transfusion plasma and biopharmaceuticals derived from this precious raw material. According to a possible epidemiological model, the risk in many European countries is the same or lower than that of human immunodeficiency virus. Comprehensive investigations have shown that the prion… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS
4 Citations
49 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 49 references

High incidence of scrapie induced by repeated injections of subinfectious prion doses

  • C Jaquemot, C Cuche, D Dormont
  • J Virol 2005;79:8904–8
  • 2005
1 Excerpt

Similar Papers

Loading similar papers…